Spruce Biosciences revenue was $7.10M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $602.0k, down 62.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, SPRB annual revenue was $10.1M, with Infinity% growth year-over-year.
SPRB past revenue growth
How has SPRB's revenue growth performed historically?
On Invalid Date, Spruce Biosciences (NASDAQ: SPRB) reported Q3 2024 revenue of $602.00 thousand up 80.41% year over year. In the same quarter last year, Spruce Biosciences's revenue was $3.07 million.
What was Spruce Biosciences's revenue in 2023?
Spruce Biosciences's annual revenue for the twelve months ending Dec 31, 2023 was $10.09 million, a Infinity% increase year over year.
How much does Spruce Biosciences make in a day?
Based on Spruce Biosciences annual revenue for the past five years, SPRB makes an average of $5,528.22 per day.
What was Spruce Biosciences's annual revenue growth in the past year?
As of Q1 2025, Spruce Biosciences's revenue has grown -1.4% year over year. This is 1,127.72 percentage points lower than the US Biotechnology industry revenue growth rate of 1,126.32%. Spruce Biosciences's revenue in the past year totaled $7.10 million.
How much does Spruce Biosciences make in a year?
Spruce Biosciences's revenue by year for the past five years is:
Spruce Biosciences's revenue for the twelve months ending Dec 31, 2023 was $10.09 million, a Infinity% increase year over year.
Spruce Biosciences's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
Spruce Biosciences's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Spruce Biosciences's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
Spruce Biosciences's annual revenue for 2019 was $0.00, a N/A decrease from 2018.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.